The Associations Between Pharmacologic Gastric Acid Suppression and Adverse Outcomes in Patients With COVID-19.

Dai, Cong; Jiang, Min; Huang, Yu-Hong

Dai, Cong; Jiang, Min; Huang, Yu-Hong.

Dai C; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Jiang M; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Huang YH; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.

Gastroenterology ; 161(5): 1722, 2021 11.

Article in English | MEDLINE | ID: covidwho-1483162

Subject(s)

COVID-19; Gastric Acid; Humans; Proton Pump Inhibitors/adverse effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastric Acid / COVID-19 Limits: Humans Language: English Journal: Gastroenterology Year: 2021 Document Type: Article Affiliation country: J.gastro.2021.03.012

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google